Evidence map›Paper›PMID 24423779›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2014

Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review.

Scott D Bieber, John Burkart, Thomas A Golper, Isaac Teitelbaum, Rajnish Mehrotra

Registry-linked trialOpen access · greenAbstract readComparative StudyReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05449067 (Nocturnal Automated Versus Continuous Ambulatory Peritoneal Dialysis in Patients With End-Stage Kidney Disease), which is not on this map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05449067 nacompletednot on this mapstarted 2022, after this paper: background citation

Nocturnal Automated Versus Continuous Ambulatory Peritoneal Dialysis in Patients With End-Stage Kidney Disease: A Multicenter, Randomized, Open-Label, Crossover Non-Inferiority Trial

TypeinterventionalSponsorNanfang Hospital, Southern Medical UniversityRan2022 to 2026Enrolled137ConditionsEnd-Stage Kidney Disease, Peritoneal DialysisArmsNocturnal automated peritoneal dialysis (APD), Continuous Ambulatory Peritoneal Dialysis (CAPD)
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Automated Peritoneal Dialysis: Patient Perspectives and Outcomes.International journal of nephrology and renovascular disease · 2021
    Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Scott D BieberUniversity of Washington, Seattle, WA. Electronic address: scbieber@u.washington.edu.
John BurkartWake Forest University, Winston-Salem, NC.
Thomas A GolperVanderbilt University, Nashville, TN.
Isaac TeitelbaumUniversity of Colorado, Denver, CO.
Rajnish MehrotraUniversity of Washington, Seattle, WA.
University of Washington · USUniversity of Colorado Denver · USVanderbilt University · USWake Forest University · US

Funding

Comparative Effectiveness of Dialysis ModalitiesR01DK095668 · NIDDK · UNIVERSITY OF WASHINGTON · PI KALANTAR-ZADEH, KAMYAR, MEHROTRA, RAJNISH · 2012 to 2014
$1.0M
NIDDK NIH HHS R01 DK095668NIDDK NIH HHS R01DK95668
6 · The paper itself

Abstract

Automated methods for delivering peritoneal dialysis (PD) to persons with end-stage renal disease continue to gain popularity worldwide, particularly in developed countries. However, the endeavor to automate the PD process has not been advanced on the strength of high-level evidence for superiority of automated over manual methods. This article summarizes available studies that have shed light on the evidence that compares the association of treatment with continuous ambulatory PD or automated PD (APD) with clinically meaningful outcomes. Published evidence, primarily from observational studies, has been unable to demonstrate a consistent difference in residual kidney function loss rate, peritonitis rate, maintenance of euvolemia, technique survival, mortality, or health-related quality of life in individuals undergoing continuous ambulatory PD versus APD. At the same time, the future of APD technology appears ripe for further improvement, such as the incorporation of voice commands and expanded use of telemedicine. Given these considerations, it appears that patient choice should drive the decision about PD modality.

Indexed as

Peritoneal Dialysis, Continuous AmbulatoryEquipment DesignHumansKidney Failure, ChronicPeritoneal DialysisPeritonitisQuality of LifeTelemedicineTreatment Outcomeautomated peritoneal dialysis (APD)continuous ambulatory peritoneal dialysis (CAPD)End-stage renal disease (ESRD)health-related quality of lifemortalityperitoneal dialysis (PD)peritonitisresidual kidney function

Identifiers

PMID24423779
PMCPMC4300314
OpenAlexW2129834434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.